Current CDC surveillance data indicate no active outbreaks meeting the stringent criteria for a Level 4 Travel Health Notice, defined as extreme risk with no available precautions. Routine monitoring of influenza, mpox, Ebola in the Democratic Republic of the Congo, and dengue shows moderate transmission without exponential growth or novel high-fatality variants as of late May 2026. Recent notices remain at Level 1 for dengue across 16 countries and Level 2 for polio in 32 nations, consistent with historical patterns of contained circulation. This stable epidemiological baseline, absent sudden escalations in case counts or transmissibility, underpins trader consensus favoring no new Level 4 issuance through year-end, though evolving model projections or unexpected variant emergence could shift conditions.
Polymarketデータを参照したAI生成の実験的な要約。これは取引アドバイスではなく、このマーケットの解決方法には一切関係ありません。 · 更新日はい
$71,829 Vol.
$71,829 Vol.
はい
$71,829 Vol.
$71,829 Vol.
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
マーケット開始日: Jan 19, 2026, 3:15 PM ET
Resolver
0x65070BE91...A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Resolver
0x65070BE91...Current CDC surveillance data indicate no active outbreaks meeting the stringent criteria for a Level 4 Travel Health Notice, defined as extreme risk with no available precautions. Routine monitoring of influenza, mpox, Ebola in the Democratic Republic of the Congo, and dengue shows moderate transmission without exponential growth or novel high-fatality variants as of late May 2026. Recent notices remain at Level 1 for dengue across 16 countries and Level 2 for polio in 32 nations, consistent with historical patterns of contained circulation. This stable epidemiological baseline, absent sudden escalations in case counts or transmissibility, underpins trader consensus favoring no new Level 4 issuance through year-end, though evolving model projections or unexpected variant emergence could shift conditions.
Polymarketデータを参照したAI生成の実験的な要約。これは取引アドバイスではなく、このマーケットの解決方法には一切関係ありません。 · 更新日
外部リンクに注意してください。
外部リンクに注意してください。
よくある質問